http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2093083-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e05ecc55c1afdb18fa200bbf0bb4c642 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0461 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107 |
| filingDate | 1993-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76280fe1a6598863b6327010ac930f3a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c44d878d59d63ef95a12b1c04f8e3207 |
| publicationDate | 1993-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2093083-A1 |
| titleOfInvention | X-ray contrast compositions and method for their use in the visualization of the gi tract |
| abstract | ABSTRACT Disclosed is an orally or rectally administrable X-ray contrast formulation in the form of an aqueous dispersion or emulsion for X-ray examination of the gastrointestinal tract, comprising: (A) 1 to 50% w/v of a non-aqueous phase; (B) 0.001 to 75% w/v of an iodine-containing X-ray contrast agent having the formula: (I) (wherein: R is an alkyl group containing from 2 to 8 carbon atoms which is unsubstituted or substituted by a C1-C6 alkyl, hydroxyl or C1-C6 alkoxy substituent; and n is an integer of 1 to 5); (C) 0 to 10% w/v of at least one surfactant; (D) 0 to 20% w/v of at least one physiologically acceptable excipient, not including the surfactant (C); and (E) water in an amount more than 0 and sufficient to make the total 100% w/v and a method of its use in diagnostic radiology of the gastrointestinal tract. |
| priorityDate | 1992-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 113.